Genomic EQA Directory

Overview:

GenQA is the first genomic EQA provider to offer an EQA for the whole multidisciplinary team e.g. laboratory staff and clinicians.  Input from both scientific and clinical staff is critical to ensuring accurate interpretation of genomic testing results. These educational multi-stage scenarios are based on real cases requiring interpretation of clinical information and test results.

• Genomic MDT rare disease EQA - To ensure the whole team is included, cases will be provided where either MDT discussion is required prior to issuing of the laboratory report, or where a laboratory report requires review or update following MDT discussion.
• Genomic molecular tumour board (MTB) for lung cancer - An educational multi-stage case scenario based on a real clinical case requiring interpretation of test results, recording of MTB discussion and outcome of MTB. 

Summary information:

Assess your variant classification, clinical interpretation and reporting of a variety of results.

• EQAs delivered in accordance with the international standard ISO 17043 for proficiency testing providers.
• Cases based on real clinical scenarios.
• 12 weeks to complete the case(s) and submit results.
• Submitted results are assessed by an expert panel.
• Each participant receives an Individual Centre Report (ICR) and EQA summary report detailing general findings, common errors and benchmarking against other participants worldwide.